Key facts
- Hesta Health’s last known valuation is $10.3M (Jul 2025).
- It has raised $2.7M; the latest was Seed Round ($2.7M) in Jul 2025.
- Notable investors include Ascension, Blue Lion Capital, Eka Ventures, Samos Investments.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Hesta Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Hesta Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hesta Health
Provider of clinical support systems designed for maternal and postnatal healthcare delivery. The company facilitates collaboration between patients and healthcare professionals, integrates early-stage diagnostics, supports longitudinal care tracking, and allows data-driven decision-making, enabling women's health practitioners to improve continuity of care, personalize treatment pathways, and contribute to research-driven improvements in reproductive and perinatal health outcomes.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 2
- Website
- hestahealth.com/
- Ownership
- Privately Held (backing)
Hesta Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hesta Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hesta Health in its N-PORT filings yet. We sweep new filings monthly.